» Articles » PMID: 33869984

Progress in Mimicking Brain Microenvironments to Understand and Treat Neurological Disorders

Overview
Journal APL Bioeng
Date 2021 Apr 19
PMID 33869984
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Neurological disorders including traumatic brain injury, stroke, primary and metastatic brain tumors, and neurodegenerative diseases affect millions of people worldwide. Disease progression is accompanied by changes in the brain microenvironment, but how these shifts in biochemical, biophysical, and cellular properties contribute to repair outcomes or continued degeneration is largely unknown. Tissue engineering approaches can be used to develop models to understand how the brain microenvironment contributes to pathophysiological processes linked to neurological disorders and may also offer constructs that promote healing and regeneration . In this Perspective, we summarize features of the brain microenvironment in normal and pathophysiological states and highlight strategies to mimic this environment to model disease, investigate neural stem cell biology, and promote regenerative healing. We discuss current limitations and resulting opportunities to develop tissue engineering tools that more faithfully recapitulate the aspects of the brain microenvironment for both and applications.

Citing Articles

Differential Lipid Signatures of Lumbar and Cisternal Cerebrospinal Fluid.

Toft-Bertelsen T, Andreassen S, Norager N, Simonsen A, Hasselbalch S, Juhler M Biomolecules. 2024; 14(11).

PMID: 39595607 PMC: 11591603. DOI: 10.3390/biom14111431.


Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ-on-a-Chip Technology.

Pramotton F, Spitz S, Kamm R Adv Sci (Weinh). 2024; 11(32):e2403892.

PMID: 38922799 PMC: 11348103. DOI: 10.1002/advs.202403892.


Leveraging Biomaterial Platforms to Study Aging-Related Neural and Muscular Degeneration.

Hidalgo-Alvarez V, Madl C Biomolecules. 2024; 14(1).

PMID: 38254669 PMC: 10813704. DOI: 10.3390/biom14010069.


Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases.

Ramasubramanian B, Reddy V, Chellappan V, Ramakrishna S Biosensors (Basel). 2022; 12(12).

PMID: 36551143 PMC: 9775999. DOI: 10.3390/bios12121176.


Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis.

Tortorella I, Argentati C, Emiliani C, Morena F, Martino S Cells. 2022; 11(19).

PMID: 36231055 PMC: 9563116. DOI: 10.3390/cells11193093.


References
1.
Janes K . Cell-to-Cell Transcript Variability: Seeing Signal in the Noise. Cell. 2015; 163(7):1566-8. PMC: 4926623. DOI: 10.1016/j.cell.2015.12.010. View

2.
Chambers S, Fasano C, Papapetrou E, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27(3):275-80. PMC: 2756723. DOI: 10.1038/nbt.1529. View

3.
Freimann F, Muller S, Streitberger K, Guo J, Rot S, Ghori A . MR elastography in a murine stroke model reveals correlation of macroscopic viscoelastic properties of the brain with neuronal density. NMR Biomed. 2013; 26(11):1534-9. DOI: 10.1002/nbm.2987. View

4.
Zhang D, Pekkanen-Mattila M, Shahsavani M, Falk A, Teixeira A, Herland A . A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons. Biomaterials. 2013; 35(5):1420-8. DOI: 10.1016/j.biomaterials.2013.11.028. View

5.
Cook D, Nguyen C, Chun H, Llorente I, Chiu A, Machnicki M . Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke. J Cereb Blood Flow Metab. 2016; 37(3):1030-1045. PMC: 5363479. DOI: 10.1177/0271678X16649964. View